Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals
(TTPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Xerava
Eravacycline
2018-08-27
2029-2037
Infections
,
Bacterial infections
,
Intraabdominal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Eravacycline
chronic kidney failure
,
kidney diseases
,
healthy volunteers/patients
,
hematologic neoplasms
,
neutropenia
,
neoplasms
,
intraabdominal infections
,
urinary tract infections
,
appendicitis
,
bacterial infections
,
infections
,
bacterial pneumonia
,
sepsis
,
multiple drug resistance
,
pneumonia
,
acinetobacter baumannii
,
pulmonary infarction
,
pharmacokinetics
,
bacterial drug resistance
,
drug-related side effects and adverse reactions
Benzocaine
spinal muscular atrophy
,
chronic inflammatory demyelinating polyradiculoneuropathy
,
myasthenia gravis
Corticorelin
chronic kidney failure
,
kidney diseases
,
renal insufficiency
,
inflammation
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
Edetic acid
bacterial conjunctivitis
,
conjunctivitis
Lactams
healthy volunteers/patients
,
meningitis
,
non-hodgkin lymphoma
,
multiple myeloma
,
bacterial infections
,
fever
,
pulmonary tuberculosis
,
multidrug-resistant tuberculosis
,
infections
,
communicable diseases
,
appendicitis
,
peritonitis
,
bacterial pneumonia
,
abdominal abscess
,
ileus
,
pyelonephritis
,
pancreatitis
,
cholecystitis
,
bacterial infections and mycoses
,
chronic bronchitis
,
bronchitis
,
acute disease
,
respiratory tract diseases
,
lung diseases
,
otitis media
,
otitis
,
cross infection
,
community-acquired infections
,
abdominal pain
,
abscess
,
intestinal perforation
,
acute abdomen
,
rupture
,
mechanical ventilators
,
pneumonia
,
ventilator-associated pneumonia
,
healthcare-associated pneumonia
,
urinary tract infections
,
intraabdominal infections
,
sepsis
,
wounds and injuries
,
retinal detachment
,
dissociative disorders
Curcumin
diabetes mellitus
,
type 1 diabetes mellitus
Trinessa
phenylketonurias
Fluoroquinolone
healthy volunteers/patients
,
kidney diseases
,
retinal diseases
,
thrombosis
,
insulin resistance
,
contraception
,
lung diseases
,
urinary tract infections
,
bronchitis
,
respiratory tract infections
,
pneumonia
,
bacterial infections
,
sinusitis
,
chronic bronchitis
,
respiratory tract diseases
,
infectious skin diseases
,
bacterial skin diseases
,
bacterial pneumonia
,
community-acquired pneumonia
,
inflammation
,
prostatitis
,
bronchial diseases
,
urologic diseases
,
bacteriuria
,
skin diseases
,
maxillary sinusitis
,
otitis media
,
acute disease
,
healthcare-associated pneumonia
,
congenital abnormalities
,
nervous system diseases
,
hereditary congenital and neonatal diseases and abnormalities
,
neural tube defects
,
nervous system malformations
,
spinal dysraphism
,
neurogenic urinary bladder
,
cellulitis
,
paranasal sinus diseases
,
nose diseases
,
cystitis
,
otitis
,
infections
,
pyelonephritis
,
appendicitis
,
critical illness
,
obesity
,
retinal detachment
,
aortic dissection
,
dissociative disorders
,
musculoskeletal diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use